期刊文献+

血清铁蛋白检测在噬血细胞综合征患儿疗效评价和复发预测中的作用 被引量:4

Role of Serum Ferritin on Evaluation of Therapeutic Effect and Monitoring of Hemophagocytic Lymphohistiocytosis in Children
暂未订购
导出
摘要 目的探讨血清铁蛋白(SF)在噬血细胞综合征(HLH)患儿病情监测中的作用。方法回顾性分析2006年5月至2011年5月本院儿科收治的50例初诊HLH住院患儿临床资料,应用放射免疫分析法治疗前、复发时、治疗后检测50例HLH患儿SF水平,HLH患儿全部采用HLH-04治疗方案,比较各组治疗前后SF水平。结果①CR患儿35例中15例复发,复发时SF再次增高,与CR时SF水平比较差异有统计学意义(P<0.01)。②复发时SF水平异常增高,与缓解组相比较差异有统计学意义(P<0.01)。血清铁蛋白水平升高与复发之间相关性分析,r=0.068。结论①血清铁蛋白(SF)水平升高对HLH具有的病情监测价值,血清铁蛋白(SF)水平越高,HLH复发可能性越大;②监测HLH患儿SF水平有助于病情判断,其值变化与病情活动度有关,且对临床疗效有评价作用。 Objective To investigate the role of serum ferritin (SF) on evaluation of monitoring in children with hemophagocytic lymphohistiocytosis(HLH). Methods Fifty children with HLH from May 2006 to May 2011 were retrospectively analyzed in the Central Hospital of Nanyang City. The levels of SF were detected regularly by radio-immunoassay in 50 children with HLH.All children applied scheme of HLH-04.The levels of SF before and after treatment were compared, and to discuss the clinical value of SF. Results 0)Seven cases with CR recurrenced. The levels of SF increased again when recurrence, which were significantly different with those of CR(P〈0.01). ~The relation of SF and recurrence is r=0.068.Conclusions O SF is a valuable marker for the evaluation of therapeutic effect of HLH. The SF level washigher, the bigger was reliability for the evaluation of therapeutic effect of HLH. (2)The detecting of SF not only play an importent role in the diagnosis, but also in monitoring recurrence and curative effect assessment of hemopbagocytic lymphohistiocytosis.
作者 向金峰
出处 《中国医药指南》 2013年第19期55-56,共2页 Guide of China Medicine
关键词 噬血细胞综合征 血清铁蛋白 复发预测 Hemophagocytic lymphohistiocytosis Serum ferritin Monitoring recurrence
  • 相关文献

参考文献3

二级参考文献10

  • 1Chandra P, Chaudhery SA, Rosener F, et al. Transient histocytosis with striking phagocytosis of platelets, leukocytes and erythrocytes. Arch Intern Med, 1975; 135:989 -991
  • 2Janka G, Zur Stadt U. Familial and acquired hemophagocytic lym- phohistiocytosis. Hematology Am Soc Hematol Educ Program, 2005 : 82 - 88
  • 3Janka G, Imashuku S, Elinder G, et al. Infection and malignancy- associated hemophagocytic syndromes. Hematol Oncol Clin Nonrth Am, 1998; 12:435-444
  • 4Henter JI, Home AC, Arico M, et al. HLH-2004: Diagnostic and Therapeutic Guidelines for Hemophagocytic Lymphohistiocytosis, Pediatr Blood Cancer 2007 ;48:124 - 131
  • 5Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. EurJ Pediatr, 2007; 166:95 -109
  • 6Evans DL, Pedersen CA, Folds JD. Major depression and immunity : preliminary evidence of decreased natural killer cell populations. Prog Neuropsychopharmacol Biol Psychiatry. 1988 ; 12:739 -748
  • 7Kontopoulou T, Tsaousis G, Vaidakis E , et al . Hemophagocytic syndrome in association with visceral leishmaniasisJ. Am J Med, 2002; 113:439-440
  • 8Eguchi K. Systemic lupus erythematosus complicated by cytomegalo- virus- induced hemophagocytic syndrome and colitis. Intern Med, 2002; 41:77 -78
  • 9Bielekova B, Catalfamo M, Reichert-Scrivner S, et al. Regulatory CD56(bright) natural killer cells mediate immunomodulatory effects of IL-2Ralpha-targeted therapy (daclizumab) in multiple sclerosis. Proc Natl Acad Sci USA, 2006; 103:5941 -5946
  • 10Koizumi K, Haseyama Y, Machino R, et al. The hemophagocytic syndrome in prostate cancer revealed by disseminated carcinomatosis of the bone marrow. J Uro, 2002; 168:1101 -1102

共引文献43

同被引文献27

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部